The Progression of Lyme Disease and the Road to Chronic Illness
By Dr. Alice Honican, Lead Practitioner at Longevity Health Center
The Three Phases of Lyme Disease: Why Timing, Immunity, and Strategy Matter
In Part 1, we explored why Lyme disease is so controversial, how it spreads, and why it is often missed or misunderstood. In Part 2, we will look more closely at how Lyme disease progresses in the body, why early treatment sometimes works, and why for many patients it does not.
Lyme disease is not a single, static illness. It is a dynamic, evolving infection. As the bacteria adapt, the immune response changes, and treatment approaches that once worked may no longer be effective. Understanding the three phases of Lyme disease is essential for understanding why chronic illness develops.
Phase One: Acute Infection and the Immune Alarm
Phase One can be described as the initial stage of infection. This occurs immediately after exposure to Borrelia burgdorferi and any accompanying co-infections.
During this phase, the immune system responds rapidly. Killer T cells are activated and dispersed throughout the body in an effort to destroy the invading organisms. This results in an acute inflammatory response, often producing flu-like symptoms and sometimes a characteristic rash.
Phase One represents a critical window of opportunity. When Lyme disease is identified early, antibiotics may be effective at killing the bacteria before they penetrate the cells. The length of this window varies significantly between individuals.
In some patients, especially those exposed to multiple co-infections, the bacteria may enter cells within hours. In others, the immune system may delay cellular penetration for weeks or even months, allowing antibiotics more time to be effective. Immune strength, stress levels, toxic load, and overall health all influence this process.
Phase Two: Intracellular Lyme and Chronic Infection
Phase Two begins when Borrelia crosses the cell membrane and moves inside the cell. Once intracellular, the bacteria are protected from both the immune system and most antibiotics.
At this stage, symptoms often become more complex and persistent. Patients may experience cycles of improvement and relapse as the bacteria remain dormant until conditions allow them to replicate and exit the cell.
Herbal therapies and immune-supportive treatments may still be effective during Phases One and Two. Strengthening immune function and supporting the body’s internal environment may help limit further progression.
Many patients in this phase are told that their infection has been treated successfully, despite ongoing symptoms. They may receive a diagnosis of post-treatment Lyme disease syndrome, even though the infection has not been fully eradicated.
Phase Three: Autoimmune Lyme and Immune Confusion
Phase Three is often the most debilitating and the least recognized stage of Lyme disease. In this phase, the immune system shifts from attacking the bacteria to attacking the body itself.
Because Borrelia is able to hide inside cells, the immune system cannot eliminate it directly. Instead, the immune response shifts toward a Th2 pattern, activating B cells to produce antibodies. These antibodies cannot enter the cell to reach the bacteria.
When bacterial structures closely resemble human tissue, the immune system begins producing antibodies against the infected host cells. This process, known as molecular mimicry, leads to autoimmune reactions.
Antibodies may target neurons, glial cells, thyroid tissue, muscle, or connective tissue. As antibody production increases, inflammation worsens and symptoms intensify. Many patients are diagnosed with autoimmune conditions during this phase, without recognition of the underlying infection.
The Conventional Medical Model and Its Limitations
Conventional medicine generally views Lyme disease as a tick-borne infection that occurs primarily in the northeastern and upper midwestern United States. Diagnosis is based on antibody testing and clinical symptoms, and treatment usually consists of a short course of antibiotics.
According to this model, patients treated early should recover fully. If symptoms persist, they are often labeled as having post-treatment Lyme disease syndrome, with the assumption that lingering symptoms are due to tissue damage rather than ongoing infection.
For many patients, this explanation does not match their lived experience.
Major Controversies in Lyme Diagnosis and Treatment
Transmission Is Not Limited to Ticks
While ticks are a primary vector, some clinicians and researchers believe Lyme disease may also be transmitted through other biting insects, sexual contact, congenital transmission, blood transfusions, and possibly contaminated animal products. These possibilities are largely excluded from standard diagnostic frameworks.
Geography Does Not Define Risk
Although official guidelines emphasize the Northeast and Upper Midwest, patients throughout the United States report Lyme disease symptoms. Climate change, habitat disruption, and expanding tick populations challenge the idea that Lyme disease is geographically limited.
The Bull’s-Eye Rash Is Inconsistent
The classic bull’s-eye rash is often emphasized in medical education, yet studies suggest it occurs in far fewer patients than commonly believed. Many people never notice a rash or a tick bite, especially since nymph ticks are tiny and painless.
Laboratory Testing Is Inadequate
Standard Lyme tests measure antibodies, not the bacteria itself. Antibodies may take weeks to develop, may never appear in immunocompromised patients, or may be suppressed by medications such as steroids or antibiotics.
Testing often fails to detect co-infections and may only identify one strain of Borrelia, despite the existence of many genospecies. There is no reliable test to confirm when treatment is complete.
Antibiotics Have Significant Limitations
Antibiotics are most effective during early infection. Once Borrelia becomes intracellular, forms cysts, or hides within biofilms, antibiotics are far less effective. Long-term use may weaken the immune system, disrupt gut health, promote fungal overgrowth, and contribute to antibiotic resistance.
Lyme disease progresses through distinct stages, and each stage requires a different therapeutic approach.
Chronic Lyme Disease and the Great Imitator
Lyme disease is known as the second great imitator because its symptoms resemble many other illnesses. It can present as fibromyalgia, chronic fatigue syndrome, multiple sclerosis, Alzheimer’s disease, or psychiatric disorders.
Symptoms may include headaches, joint pain, neurological dysfunction, heart palpitations, dizziness, and cognitive impairment. The incubation period and symptom expression vary widely.
Many patients appear healthy on the outside and have normal lab results, yet suffer profoundly. This is why Lyme disease is often referred to as the invisible illness.
Lyme Disease and the Brain
The brain has limited immune defenses. In early infection, the blood brain barrier becomes more permeable, allowing Lyme bacteria and immune cells to enter the brain. This can lead to inflammation and a wide range of neurological and psychiatric symptoms.
Depending on where the infection localizes, symptoms may include memory loss, mood changes, anxiety, psychosis, or dementia-like presentations. In some cases, what appears to be a primary neurological or psychiatric disorder may actually be a chronic brain infection.
Why Each Case of Lyme Is Different
The severity and progression of Lyme disease depend on many factors, including immune strength, toxic burden, stress levels, co-infections, age, and detoxification capacity.
Some patients test positive with minimal symptoms, while others test negative and are severely ill. Many are misdiagnosed for years with other conditions and never realize Lyme disease is the underlying cause.
This complexity is why a personalized and holistic approach is essential. Coming up in part 3, we will explore how a holistic, integrative approach that addresses infections, toxins, immune function, lifestyle, and individualized therapies can create a realistic path toward healing and recovery from chronic Lyme disease.
